Chargement en cours...
Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells
BACKGROUND: Curative treatments for patients with metastatic synovial sarcoma (SS) do not exist, and such patients have a poor prognosis. We explored combinations of molecularly-targeted and cytotoxic agents to identify synergistic treatment combinations in SS cells. METHODS: Two SS cell lines (HS-S...
Enregistré dans:
| Publié dans: | BMC Res Notes |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4247709/ https://ncbi.nlm.nih.gov/pubmed/25406429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-7-812 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|